PresentationJason ColomaCEO & Director Good morning, everyone. I'm Jason Coloma. I'm the CEO of Maze Therapeutics. And first of all, I'd like to thank the Jefferies team for inviting us to this year's conference. I'd also like to acknowledge our forward-looking statements. At Maze, our mission is simple, yet ambitious, to harness the power of human genetics to transform the lives of patients. An emphasis for us is chronic kidney disease. Kidney disease is a silent killer. Over 800 million individuals global ...